Effectiveness and Persistence in SB4- and Reference Etanercept-Treated Rheumatoid Arthritis Patients in Ordinary Clinical Practice in Norway.
Arthritis care & research（2023）
摘要
Outcomes for disease status/drug persistence at week 52 were similar between patients with RA treated with etanercept or SB4.
更多查看译文
关键词
rheumatoid arthritis patients,rheumatoid arthritis,reference etanercept–treated,clinical practice,ordinary clinical practice
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要